The field of cancer immunotherapy has gained significant attention as a promising therapeutic approach, especially in light ...
The field of oncology research is increasingly focusing on understanding the tumor microenvironment (TME), particularly its implications for drug ...
As we mark Breast Cancer Awareness Month this October, we celebrate the work of Kornelia Polyak, a pioneering cancer ...
Over the past decade, the advent of immune checkpoint blockade (ICB) therapy has transformed cancer treatment. Unlike conventional cytotoxic and targeted therapies, immunotherapy leverages both the ...
Spatial biology is reshaping how researchers study cancer by revealing the architecture and complexity of tumors in extraordinary detail. Through techniques that combine protein- and gene-level ...
Scientists at Virginia Tech's Fralin Biomedical Research Institute at VTC and their collaborators are exploring emerging ...
Following successful early access pilots with leading biopharma partners, Aignostics today announced the general availability of Atlas H&E-TME, an application for analyzing the tumor microenvironment ...
First U.S. patient dosed at a mid-tier dose level where multiple responses have been observedMulti-regional trial to accelerate time to ...
Oncotelic Therapeutics, Inc. (OTCQB: OTLC), a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat cancer patients by leveraging its novel PDAOAI ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback